THE H014 DIARIES

与单独化疗相比，化疗中添加阿米万他单抗和拉泽替尼可使进展或死亡风险降低Dr. Liao observed: "H002 has shown in preclinical reports the two solid and broad-spectrum routines towards various EGFR mutation combos, and large selectivity and protection profile. The drug candidate has good prospective to take care of prior